Table 1.
Patient Demographic and Individual Patients PET Results.
| Patient No./Age/Gender | Cancer Type/Target Lesion Location | Highest Visual Uptake | Tumor SUVmax | Blood SUVmean | ||||
|---|---|---|---|---|---|---|---|---|
| 1 hour | 3 hours | 24/48 hours | 1 hour | 3 hours | 24/48 hours | |||
| 1/62/M | Esophageal cancer/mediastinal lymph node | None | 0.54 | 0.19 | 0.31 | 16.44 | 10.17 | 7.70 |
| 2/67/F | Gastrointestinal primary/pelvic mass | Mild | 4.90 | 7.20 | 9.10 | 10.0 | 8.40 | 6.44 |
| 3/56/M | Esophageal cancer/primary tumor | Mild | 5.50 | 5.20 | 6.19 | 10.05 | 8.76 | 5.34 |
| 4/21/M | Ewing sarcoma/iliac mass | Minimal | 2.90 | 4.33 | 5.52 | 5.31 | 6.71 | 3.08 |
| 5/61/M | Malignant melanoma/thigh soft tissue mass | Mild | 4.70 | 5.13 | 4.03 | 10.60 | 8.19 | 4.06 |
| 6/65/M | Colon cancer/iliac lymph node | None | 1.49 | 1.33 | 1.36a | 6.27 | 7.29 | 2.23a |
| 7/59/M | Lung cancer/primary tumor | Mild | 6.10 | 4.49 | 4.45 | 10.71 | 10.86 | 9.55 |
| 8/54/F | Lung cancer/primary tumor | Mild | ND | 2.5 | 2.2 | ND | 7.83 | 5.26 |
| 9/66/F | Hemangiosarcoma/llung mass | Minimal | 4.30 | 4.22 | 2.90 | 11.90 | 10.60 | 6.55 |
| 10/68/M | Pleomorphic liposarcoma/pleural mass | Mild | 5.70 | 3.70 | 6.91 | 10.52 | 8.62 | 6.11 |
| 11/33/M | Osteosarcoma/thigh mass | Mild | 3.64 | 3.44 | 4.25 | 3.35 | 2.92 | 4.91 |
Abbreviations: F, female; M, male; ND, imaging was not done; PET, positron emission tomography; SUVmax, maximum standardized uptake value.
aImaging performed 4 days after injection.